Status: Recruiting
Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
This study is a prospective, non-randomized, observational, post-market follow-up trial designed to evaluate the safety and efficacy of the RENATUS® Transcatheter Aortic Valve System for the treatment of severe aortic stenosis.
Participants needed: 800
Trial details
Age: 60-100Biological sex: AllType: InterventionalSponsor: Beijing Balance Medical Technology Co., LtdUpdated: Feb 17, 2026Locations: 4
Eligibility criteria
Patients deemed eligible for TAVR by the treating physician, including those at... [+4]
Patients with a life expectancy of ≤1 year following prosthetic valve implantati... [+17]